CDR substitutions of a humanized monoclonal antibody (CC49): contributions of individual CDRs to antigen binding and immunogenicity
- 1 October 1999
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 36 (15-16) , 1079-1091
- https://doi.org/10.1016/s0161-5890(99)00094-2
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-γ-interferon antibodyJournal of Molecular Recognition, 1999
- Crystal structures of a rat anti-CD52 (CAMPATH-1) therapeutic antibody fab fragment and its humanized counterpartJournal of Molecular Biology, 1998
- Clinical comparison of radiolocalization of two monoclonal antibodies (mAbs) against the TAG-72 antigenNuclear Medicine and Biology, 1994
- Preselection of Patients with High TAG-72 Antigen Expression Leads to Targeting of 94% of Known Metastatic Tumor Sites with Monoclonal Antibody I-131-CC49Cancer Investigation, 1994
- Expression of Colorectal Carcinoma-Associated Antigens in Colonic PolypsJournal of Surgical Research, 1993
- Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72Cancer Immunology, Immunotherapy, 1993
- Humanized antibodiesImmunology Today, 1993
- A general method for rapid site-directed mutagenesis using the polymerase chain reactionGene, 1990
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- The protein data bank: A computer-based archival file for macromolecular structuresJournal of Molecular Biology, 1977